Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060255) titled 'Safety Evaluation of Excessive Intake of Maizinol (UP165) in Healthy Adults' on Jan. 5.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Unigen Inc.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety of Maizinol (UP165) following 4 weeks of excessive intake in healthy adults, focusing on adverse events and changes in clinical laboratory parameters.
Basic objectives2 -...